Applied Molecular Transport (AMTI) Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Applied Molecular Transport in the last year. There are currently 2 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AMTI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMTI, but not buy additional shares or sell existing shares.
View AMTI analyst ratings or view top-rated stocks.

Applied Molecular Transport's stock was trading at $0.42 at the start of the year. Since then, AMTI shares have decreased by 39.7% and is now trading at $0.2531.
View the best growth stocks for 2023 here.

Applied Molecular Transport saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 514,300 shares, an increase of 15.2% from the April 30th total of 446,600 shares. Based on an average daily trading volume, of 185,500 shares, the short-interest ratio is currently 2.8 days. Approximately 2.0% of the shares of the company are short sold.
View Applied Molecular Transport's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our AMTI earnings forecast.

Applied Molecular Transport Inc. (NASDAQ:AMTI) issued its quarterly earnings results on Thursday, March, 9th. The company reported ($0.58) earnings per share for the quarter, topping the consensus estimate of ($0.66) by $0.08.

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Molecular Transport investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), Raytheon Technologies (RTX), Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Cisco Systems (CSCO), Johnson & Johnson (JNJ) and Resideo Technologies (REZI).

(AMTI) raised $130 million in an initial public offering (IPO) on Friday, June 5th 2020. The company issued 10,000,000 shares at a price of $12.00-$14.00 per share. BofA Securities, Jefferies and SVB Leerink acted as the underwriters for the IPO.

Applied Molecular Transport trades on the NASDAQ under the ticker symbol "AMTI."

Applied Molecular Transport's stock is owned by many different retail and institutional investors. Top institutional shareholders include EPIQ Capital Group LLC (22.25%), Renaissance Technologies LLC (0.69%), Two Sigma Advisers LP (0.43%) and Two Sigma Investments LP (0.39%). Insiders that own company stock include Aaron Vandevender, Bittoo Kanwar, Brandon Hants, David Lamond, Douglas A Rich, Elizabeth Bhatt, Epiq Capital Group, Llc, Helen Susan Kim, Randall PhD Mrsny, Shawn Cross and Tahir PhD Mahmood.
View institutional ownership trends.

Shares of AMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMTI stock can currently be purchased for approximately $0.25.

Applied Molecular Transport (NASDAQ:AMTI) has a market capitalization of $9.96 million. The company earns $-126,320,000.00 in net income (profit) each year or ($2.87) on an earnings per share basis.

The company employs 125 workers across the globe.

Applied Molecular Transport's mailing address is 1 TOWER PLACE SUITE 850, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.appliedmt.com. The company can be reached via phone at 650-392-0420 or via email at achang@appliedmt.com.